| Home > Publications database > Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma. > Access to Fulltext |
s13046-026-03725-3_reference-2
|
|||||||
| version 1 |
| ||||||